The Effect of High-dose Remifentanil on the Reversal of Neuropathic Pain in Postherpetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2016
At a glance
- Drugs Remifentanil (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Acronyms RemiHighDose PHZ
- 18 Nov 2016 Status changed from recruiting to completed.
- 22 Jun 2011 New trial record